Cancer-biomarkers
Cancer biomarkers are critical indicators used in diagnosing, prognosis, and treating cancer. These biomarkers, which can be molecules, genes, or specific cellular changes, are often detected in cancer patients’ blood, tissues, or bodily fluids. They play a pivotal role in identifying the presence and type of cancer, determining the disease’s progression, and predicting the patient’s response to specific treatments. For instance, certain proteins or genetic mutations can signal the presence of specific cancer types and guide the choice of targeted therapies. Furthermore, monitoring these biomarkers during and after treatment can help assess the effectiveness of therapy and detect any recurrence of the disease early. The ongoing research and development in this field aim to discover more specific and sensitive biomarkers, thereby enhancing early cancer detection, improving survival rates, and paving the way for more personalized cancer treatment strategies.
Cancer-biomarkers
Latest Posts
-
Revolutionizing Breast Cancer Prognosis with Novel Digital Biomarker Histomic Prognostic Signature(HiPS): A New AI-Driven Approach
The Northwestern Medicine study introduces a novel digital biomarker, the Histomic Prognostic Signature (HiPS), using a new deep learning-based AI tool designed to improve breast cancer prognosis. Traditional methods, like the Nottingham criteria used by pathologists, focus…
-
Using ribosomal protein expression patterns as cancer biomarker
A research team at the University of Basel’s Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. The study is reported in journal Genome Biology.…
-
Liquid biopsy chip based on carbon nano-tubes to detect circulating cancer cells
A chip developed by mechanical engineers at Worcester Polytechnic Institute (WPI) can trap and identify metastatic cancer cells in a small amount of blood drawn from a cancer patient. The breakthrough technology uses a simple mechanical method…
-
New lung cancer biomarker Protein PD-1 for predicting survival
The biomarker PD-1, a protein, could potentially be used to predict survival or disease-free survival of lung cancer patients who have had the tumor surgically removed. This is substantiated by the results of a study conducted under…
You must be logged in to post a comment.